Literature DB >> 15038614

High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies.

Ditte C Andersen1, Claus Koch, Charlotte H Jensen, Karsten Skjødt, Jette Brandt, Børge Teisner.   

Abstract

A sandwich ELISA for quantification of the endometrial protein PP14 revealed false positive reactions in 81% of male sera (n = 54). The PP14 ELISA was based on two monoclonal antibodies (Mabs) with different epitope specificities--a catcher and a biotinylated indicator. The monoclonal antibodies were purified by protein G affinity chromatography from culture supernatant containing 10% (v/v) fetal calf serum (FCS). Human anti-animal IgG (bovine, mouse, horse, and swine) antibodies and human anti-bovine serum albumin antibodies were measured using an ELISA design, with direct bridging of the solid phase and biotinylated antigens. The false positive reactions were abolished by addition of 1% (v/v) bovine serum to the dilution buffer (DB). Human anti-bovine IgG antibodies (HABIA) were detected in 99 out of 104 sera from blood donors (50 females; 54 males). HABIA levels in male sera (n = 54) were positively correlated to the false positive signals in the PP14 ELISA (r = 0.923; p < 0.0001). Antibodies to IgG from other mammalian species (mouse, horse, and swine) were also detected in the donor sera, but levels and frequencies were lower compared to that of HABIA. Furthermore, HABIA were positively correlated to human anti-bovine serum albumin antibodies in the donor sera (r = 0.639; p < 0.0001; n = 103). HABIA (prevalence 95%) cause false positive reactions due to crossbinding of contaminating bovine IgG and/or crossreaction with mouse IgG in two-site immunoassays. The apparent presence of human anti-mouse IgG antibodies (HAMA), described to create false positive results, may be due to a crossreacting fraction of the polyclonal circulating antibodies against bovine IgG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15038614     DOI: 10.1081/ias-120027223

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  9 in total

Review 1.  Challenges in the clinical utility of the serum test for HER2 ECD.

Authors:  Lian Lam; Nicholas McAndrew; Marla Yee; Ting Fu; Julia C Tchou; Hongtao Zhang
Journal:  Biochim Biophys Acta       Date:  2012-04-03

2.  Functional analysis of Ficolin-3 mediated complement activation.

Authors:  Estrid Hein; Christian Honoré; Mikkel-Ole Skjoedt; Lea Munthe-Fog; Tina Hummelshøj; Peter Garred
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

3.  IL-8 and cathepsin B as melanoma serum biomarkers.

Authors:  Hongtao Zhang; Ting Fu; Suzanne McGettigan; Suresh Kumar; Shujing Liu; David Speicher; Lynn Schuchter; Xiaowei Xu
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

4.  Ribosome display selection of a murine IgG₁ Fab binding affibody molecule allowing species selective recovery of monoclonal antibodies.

Authors:  Sebastian Grimm; Feifan Yu; Per-Åke Nygren
Journal:  Mol Biotechnol       Date:  2011-07       Impact factor: 2.695

5.  Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results.

Authors:  Uffe Nygaard; Christian Vestergaard; Claus Johansen; Mette Deleuran; Malene Hvid
Journal:  Springerplus       Date:  2016-01-13

6.  False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives.

Authors:  Dimitra S Mouliou; Konstantinos I Gourgoulianis
Journal:  Expert Rev Respir Med       Date:  2021-04-25       Impact factor: 3.772

7.  A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients.

Authors:  Tue W Kragstrup; Thomas Vorup-Jensen; Bent Deleuran; Malene Hvid
Journal:  Springerplus       Date:  2013-06-15

8.  Circulating antibodies against age-modified proteins in patients with coronary atherosclerosis.

Authors:  Edina Korça; Veronika Piskovatska; Jochen Börgermann; Alexander Navarrete Santos; Andreas Simm
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

9.  Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.

Authors:  Johanna E Gehin; Rolf A Klaasen; Ellen S Norli; David J Warren; Silje W Syversen; Guro L Goll; Trine Bjøro; Tore K Kvien; Maria D Mjaavatten; Nils Bolstad
Journal:  Rheumatol Int       Date:  2021-05-04       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.